# COSENTYX

NDC: 0078-1168
Generic name: secukinumab
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20231006

FDA application: BLA761349

## Active ingredients

- SECUKINUMAB: 25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-1168"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-1168
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=77c4b13e-7df3-42d4-81db-3d0cddb7f67a